Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201206061 Principal Investigator: Naughton, Michael
Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Bevacizumab, and Associated Biomarkers in Combination with Paclitaxel Compared with Paclitaxel plus Placebo as First-Line Treatment of Patients with HER2-Negative Metastatic Breast Cancer
Phase: III Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see which patients are most likely to benefit from treatment with bevacizumab by using a simple blood test and to understand how the combination of bevacizumab with paclitaxel may improve a patient's cancer diagnosis, delay the growth of their tumor(s), and shrink their tumor(s).
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)